Oruka Therapeutics Inc. (ORKA)
NASDAQ: ORKA
· Real-Time Price · USD
15.40
0.40 (2.67%)
At close: Aug 15, 2025, 3:59 PM
15.37
-0.19%
After-hours: Aug 15, 2025, 04:10 PM EDT
Oruka Therapeutics Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 19K | 16K | 16K | -20K | 12K | 19K | 23K | 30K | 29K | 29K | 29K | 28K | 29K | 28K | 28K | 27K | 19K | 17K |
Gross Profit | -19K | -16K | -16K | 20K | -12K | -19K | -23K | -30K | -29K | -29K | -29K | -28K | -29K | -28K | -28K | -27K | -19K | -17K |
Operating Income | -28.43M | -25.09M | -30.32M | -29.45M | -25.87M | -2.48M | -1.59M | -1.94M | -1.97M | -1.8M | -1.58M | -1.76M | -2.43M | -3.28M | -5.68M | -4.72M | -4.84M | -4.1M |
Interest Income | 3.86M | 4.09M | 4.53M | 1.33M | 444K | 473K | 501K | 513K | 493K | 450K | 675K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -24.57M | -21M | -25.78M | -28.62M | -27.31M | -2.01M | -1.09M | -1.42M | -1.48M | -1.35M | -1.17M | -2.33M | -3.15M | -3.27M | -5.68M | -4.71M | -4.83M | -4.1M |
Net Income | -24.57M | -21M | -25.78M | -28.62M | -27.31M | -2.01M | -1.09M | -1.42M | -1.48M | -1.35M | -1.17M | -2.33M | -3.15M | -3.27M | -5.68M | -4.71M | -4.83M | -4.1M |
Selling & General & Admin | 4.34M | 5.14M | 4.8M | 3.76M | 2.18M | 1.67M | 1.52M | 1.58M | 1.69M | 1.38M | 1.29M | 1.2M | 1.41M | 1.07M | 1.71M | 1.25M | 1.24M | 1.21M |
Research & Development | 24.09M | 19.93M | 25.5M | 25.69M | 23.7M | 165K | 47K | 322K | 254K | 390K | 266K | 534K | 995K | 2.18M | 3.94M | 3.44M | 3.58M | 2.88M |
Other Expenses | n/a | n/a | n/a | n/a | -4.39M | 628K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 28.43M | 25.07M | 30.3M | 29.45M | 21.49M | 2.46M | 1.57M | 1.91M | 1.94M | 1.77M | 1.55M | 1.73M | 2.4M | 3.25M | 5.65M | 4.69M | 4.82M | 4.08M |
Interest Expense | n/a | n/a | n/a | 504K | n/a | 214K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 28.43M | -25.09M | 30.32M | 29.45M | 21.49M | 2.48M | 1.59M | 1.94M | 1.97M | 1.8M | 1.58M | 1.76M | 2.43M | 3.28M | 5.68M | 4.72M | 4.84M | 4.1M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 42.23M | 41.68M | 16.79M | 15.01M | 14.51M | 14.5M | 14.42M | 14.41M | 14.41M | 14.41M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.03M |
Shares Outstanding (Diluted) | 42.23M | 41.68M | 16.79M | 15.01M | 14.51M | 14.5M | 14.42M | 14.41M | 14.41M | 14.41M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.03M |
EPS (Basic) | -0.58 | -0.5 | -1.54 | -1.91 | -1.3 | -0.24 | -0.9 | -1.19 | -1.23 | -1.12 | -0.98 | -1.94 | -2.62 | -2.72 | -4.73 | -3.92 | -4.03 | -3.98 |
EPS (Diluted) | -0.58 | -0.5 | -1.54 | -1.91 | -1.3 | -0.24 | -0.9 | -1.19 | -1.23 | -1.12 | -0.98 | -1.94 | -2.62 | -2.72 | -4.73 | -3.92 | -4.03 | -3.98 |
EBITDA | -24.55M | -20.98M | -25.77M | -28.12M | -22.24M | -1.99M | -1.07M | -1.39M | -1.45M | -1.32M | -1.15M | -2.31M | -3.12M | -3.24M | -5.65M | -4.68M | -4.82M | -4.08M |
EBIT | -24.57M | -21M | -25.78M | -28.12M | -22.24M | -2.01M | -1.09M | -1.42M | -1.48M | -1.35M | -1.17M | -2.33M | -3.15M | -3.27M | -5.68M | -4.71M | -4.83M | -4.1M |
Depreciation & Amortization | 19K | 16K | 16K | -20K | 12K | 19K | 23K | 30K | 29K | 29K | 29K | 28K | 29K | 28K | 28K | 27K | 19K | 17K |